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http://djournal homepage: www.elsevier.com/locate/joaEditorialTwo decades of progress in the understanding of Brugada syndromeBrugada syndrome (BS) is a hereditary arrhythmogenic disease
characterized by a coved- or saddleback-type ST elevation in the
right precordial lead on a 12-lead electrocardiogram (ECG) and
ventricular ﬁbrillation (VF) occurring mainly at night. During the
past 2 decades, since Brugada and Brugada [1] ﬁrst described this
peculiar condition, there has been notable progress in our under-
standing of this syndrome with respect to genetics, epidemiology,
electrophysiology, and clinical ﬁndings. Hundreds of mutations in
more than 12 genes that encode sodium, potassium, or calcium
ion channels have been identiﬁed in individuals with this condi-
tion. The prevalence, incidence, and short-term prognosis of this
syndrome have also been clariﬁed. However, the exact reason for
its predominance in men and Asian individuals remains unknown,
although the effect of testosterone and the higher expression of
the transient outward potassium (Ito) current in the right ven-
tricular (RV) epicardium in men and polymorphisms that are
found only in Asian individuals are believed to be responsible
for this predominance.
The pathophysiological mechanism of this syndrome also
remains a matter of debate. There are 2 main theories that explain
the mechanism of ST elevation and ventricular arrhythmias: the
repolarization hypothesis and the depolarization hypothesis. The
repolarization hypothesis has been supported by studies using
animal models and relies on Ito-mediated transmural dispersion
of repolarization between the RV endocardium and epicardium.
This theory provides an explanation for the trigger (phase 2 reen-
try) underlying the development of VF, ST segment elevation by
calcium channel blockers or potassium channel openers, ST seg-
ment normalization by quinidine or isoproterenol, and the strong
association between spontaneous type 1 ECG and cardiac events.
In contrast, the depolarization hypothesis relies on conduction
delay in the RV outﬂow tract caused by structural abnormalities.
Although this theory has not been demonstrated in experimental
models, various data supporting the existence of RV conduction
delay have been obtained from electrophysiological studies (EPS)
and clinical studies involving signal-averaged ECGs and body
surface, epicardial, and endocardial mapping. Furthermore, Nade-
manee et al. [2] recently demonstrated that abnormal low-voltage,
prolonged, and fractionated late potentials exist in the epicardial
aspect of the RV outﬂow tract in selected BS patients who received
multiple shocks by an implantable cardioverter-deﬁbrillator (ICD).
It is unknown whether these abnormalities exist in every BS76/$ - see front matter & 2013 Japanese Heart Rhythm Society. Published by E
x.doi.org/10.1016/j.joa.2013.01.006patient and which hypothesis is more reliable. Further research
is needed to clarify these issues as well as to determine the
efﬁcacy of catheter ablation in patients with BS. The value of VF
inducibility by EPS is still a controversial topic for risk stratiﬁca-
tion in BS. Although many studies have failed to demonstrate the
usefulness of EPS, a good association between VF inducibility and
patient outcome may be obtained by using speciﬁc standardized
stimulation protocols, as reported by Makimoto et al. [3].
Thus far, a number of guidelines have been reported based on
the results of previous multicenter studies. The Japanese Circula-
tion Society proposed that ICD implantation is indicated for
patients without prior VF, when 2 of the following 3 risk factors
are present: a history of unexplained syncope, VF inducibility by
EPS, and a family history of sudden death. This guideline seems to
be appropriate for Japanese Brugada patients. Nevertheless, we
should be mindful to recommend ‘‘you don’t need to implant ICD’’
to an asymptomatic patient with a typical Brugada ECG but with
only one or no risk factor, because there are no available data of
long-term follow-up for such patients. During the past 2 decades,
research in BS has progressed markedly and we are on a steep
learning curve, even though several more years of studies may be
required until the day when we can precisely identify low or no
risk patients and conﬁdently tell them ‘‘you are safe’’.
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